Bowel ultrasound scan in the management of pediatric moderate ulcerative colitis: The applicability of international bowel ultrasound segmental activity score
Listen to this summary
The authors aimed to evaluate the effectiveness of bowel ultrasound (BUS) and the international bowel ultrasound segmental activity score (IBUS-SAS) in assessing and predicting outcomes in children with moderate ulcerative colitis. Their findings indicate that BUS is a reliable, non-invasive method for monitoring disease activity, with IBUS-SAS demonstrating good predictive capabilities for clinical remission and the need for colectomy within 12 months.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of pediatric gastroenterology and nutrition
View all →Jun 8, 2026 · Journal of pediatric gastroenterology and nutrition
Somatic and gastrointestinal symptoms longitudinally predict early adolescent disordered eating
Jun 3, 2026 · Journal of pediatric gastroenterology and nutrition
Rotational thromboelastometry versus conventional tests in decompensated cirrhotic children undergoing invasive procedures
More in Pediatrics
View all →Aug 7, 2026 · European heart journal
Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies
Aug 7, 2026 · Critical care medicine
Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis
Aug 7, 2026 · Pediatric nephrology (Berlin, Germany)
Anti-rituximab antibodies: implications for clinical outcomes and safety in pediatric idiopathic nephrotic syndrome
Aug 7, 2026 · Critical care medicine
Rethinking Muscle Wasting in Critical Illness: A Systematic Review and Meta-Analysis of Myofiber Size and Protein Turnover
Aug 7, 2026 · Critical care medicine
Telemedicine Critical Care Billing For Hospitalized Medicare Fee-For-Service Beneficiaries, 2018-2024
Aug 7, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


